title: Prostaglandin E2 attenuation of sheep lung responses to endotoxin.
abstract: Prostaglandin (PG) E2 can inhibit inflammatory responses of neutrophils and lymphocytes, including eicosanoid release. Diffuse lung injury after endotoxemia in sheep is accompanied by sequestration of neutrophils and lymphocytes in the lungs, and eicosanoids mediate some of the pathophysiology of the response. To determine whether exogenous PGE2 could prevent the endotoxin response, we measured pulmonary hemodynamics, gas exchange, and lung lymph responses to infusion of Escherichia coli endotoxin (0.5 micrograms/kg iv over 30 min) in unanesthetized sheep in the presence and absence of PGE2 (0.5 micrograms.kg-1.min-1) infused intravenously for 4 h beginning 0.5 h before endotoxin infusion. We also measured lung lymph concentrations of thromboxane B2 (TxB2) and prostacyclin metabolite, 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), by radioimmunoassay and leukotriene B4 (LTB4) by gas chromatography-mass spectrometry. PGE2 decreased endotoxin-induced pulmonary hypertension and hypoxemia and markedly attenuated the lymph flow and lymph protein clearance responses. PGE2 also attenuated endotoxin-induced increases in lung lymph TxB2 and 6-keto-PGF1 alpha and decreased lymph LTB4 flow after endotoxin without decreasing lymph LTB4 concentrations. We conclude that PGE2 infusion attenuates lung dysfunction caused by endotoxemia, possibly by preventing endogenous release of other eicosanoids.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
authors.forename: K L
authors.initials: KL
authors.lastname: Brigham
authors.forename: W
authors.initials: W
authors.lastname: Serafin
authors.forename: A
authors.initials: A
authors.lastname: Zadoff
authors.forename: I
authors.initials: I
authors.lastname: Blair
authors.forename: B
authors.initials: B
authors.lastname: Meyrick
authors.forename: J A
authors.initials: JA
authors.lastname: Oates
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D002302:Cardiac Output / Q000187:drug effects; D015232:Dinoprostone; D004731:Endotoxins / Q000494:pharmacology*; D007700:Kinetics; D007975:Leukotriene B4 / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000502:physiology*; D008196:Lymph / Q000032:analysis / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology*; D011506:Proteins / Q000032:analysis; D012756:Sheep; D013929:Thromboxane B2 / Q000032:analysis
chemical_list: D001798:Blood Proteins; D004731:Endotoxins; D011458:Prostaglandins E; D011506:Proteins; D007975:Leukotriene B4; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D015232:Dinoprostone